This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yamaguchi, H.
Right arrow Articles by Yamamoto, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yamaguchi, H.
Right arrow Articles by Yamamoto, Y.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, June 2008, p. 1991-1998, Vol. 52, No. 6
0066-4804/08/$08.00+0     doi:10.1128/AAC.01416-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Chlamydia pneumoniae Growth Inhibition in Cells by the Steroid Receptor Antagonist RU486 (Mifepristone){triangledown}

Hiroyuki Yamaguchi,1,6,7* Shigeru Kamiya,1 Tomonori Uruma,1,2 Takako Osaki,1 Haruhiko Taguchi,1 Tomoko Hanawa,1 Minoru Fukuda,3 Hayato Kawakami,4 Hajime Goto,2 Herman Friedman,5 and Yoshimasa Yamamoto5,6

Division of Microbiology, Department of Infectious Disease,1 Department of 1st Internal Medicine,2 Laboratory of Electron Microscopy,3 Department of Anatomy, Kyorin University School of Medicine, Tokyo 181-8611, Japan,4 Department of Medical Microbiology and Immunology, University of South Florida College of Medicine, Tampa, Florida 33612,5 Division of Molecular Microbiology, Department of Basic Laboratory Sciences, Osaka University Graduate School of Medicine, Osaka 565-0871, Japan,6 Department of Laboratory Sciences, College of Medical Technology, Hokkaido University, Nishi-5 Kita-12 Jo, Kita-ku, Sapporo, Hokkaido 060-0812, Japan7

Received 1 November 2007/ Returned for modification 17 February 2008/ Accepted 6 March 2008

Since steroids are powerful anti-inflammatory agents and increase susceptibility to a variety of infections, including Chlamydia (Chlamydophila) pneumoniae respiratory tract infections, the effect of the steroid receptor antagonist RU486 (mifepristone) on C. pneumoniae growth in epithelial HEp-2 cells was examined. Treatment of HEp-2 cells with RU486 significantly inhibited the growth of C. pneumoniae in a dose-dependent manner. Electron microscopic studies also revealed that the treatment of infected cells with RU486 resulted in a marked destruction of infecting organisms. The addition of the host cell protein synthesis inhibitor cycloheximide to the infected cells did not alter the inhibition of C. pneumoniae growth by RU486. Pretreatment of C. pneumoniae organisms with RU486 before addition to culture also did not result in any modulation of bacterial growth in the cells. However, the binding of RU486 to C. pneumoniae organisms in cells at 24 h after infection was demonstrated by immune electron microscopy with anti-RU486 antibody. Incubation of cells with anti-RU486 antibody completely diminished the inhibition of C. pneumoniae growth by RU486. These results indicate that RU486 may directly bind to the bacteria within cells and cause the destruction of C. pneumoniae. This novel mode of regulation of C. pneumoniae growth in cells by RU486 might provide a new approach to understanding complicated aspects of C. pneumoniae infection.


* Corresponding author. Mailing address: Department of Laboratory Sciences, College of Medical Technology, Hokkaido University, Nishi-5 Kita-12 Jo, Kita-ku, Sapporo, Hokkaido 060-0812, Japan. Phone and fax: 81-11-706-3326. E-mail: hiroyuki{at}med.hokudai.ac.jp

{triangledown} Published ahead of print on 17 March 2008.


Antimicrobial Agents and Chemotherapy, June 2008, p. 1991-1998, Vol. 52, No. 6
0066-4804/08/$08.00+0     doi:10.1128/AAC.01416-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.